ClinicalTrials.gg
CompletedNCT07393750Updated Aug 13, 2026

High-power Laser Versus Pulsed Electromagnetic Therapy in Lumbar Radiculopathy.

An interventional study of high-power laser and Pulsed electromagnetic field in Lumbar Radiculopathy, Hoffman's Reflex and Pulsed Electromagnetic Therapy, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 35 Years to 48 Years. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
35 Years to 48 Years
Sex
All
01

Study summary

To compare between high-power laser versus pulsed electromagnetic therapy on pain and Hoffman reflex in lumbar radiculopathy.

Read the detailed description

Lumbar radiculopathy is one of the most common complaints evaluated by a spine surgeon. Its prevalence has been estimated to be 3%-5% of the population, affecting both men and women. Age is a primary risk factor, as it occurs secondary to the degenerative process within the spinal column. Symptoms typically begin in midlife, with men often affected in the 40s while women are affected in the 50s and 60s. Disc herniation is one of the primary causes of lumbar radiculopathy.

The pressure exerted by the herniated disc on the longitudinal ligament and the local inflammation results in localized back pain. The lumbar radicular pain arises when disc material exerts pressure or contacts the thecal sac or lumbar nerve roots, resulting in nerve root ischemia and inflammation. The annulus fibrosus is thinner on the posterolateral aspect and lacks support from the posterior longitudinal ligament, making it vulnerable to herniations. Due to the proximity of the nerve root, a posterolateral herniation is more likely to result in nerve root compression.

High Intensity Power Laser (HILT) delivers high-intensity light energy to deep tissues in short pulses (120-200 µs). It causes minor and slow light absorption by the chromophores, which increases mitochondrial bioenergetics by causing extra adenosine triphosphate synthesis and oxygen consumption, as well as RNA and DNA production, resulting in tissue stimulation. Various studies have shown that laser light has anti-inflammatory and analgesic effects and that it reduces edema. HILT also has photothermal properties, resulting from the transformation of high-energy light into heat in tissue.

Magnetic therapy is considered as a safe, easy and non-invasive physical therapy modality used to treat pain, inflammation and other types of pathologies and diseases. Pulsed electromagnetic field (PEMF) refers to a basic law of electromagnetism that describes how a magnetic field interacts with an electric circuit to produce an electromotive force known as electromagnetic induction. Exposure to PEMF has been reported to modulate neuronal excitation and neurogenesis related to Na+ channel activity. Neurons excited by the exogenous electromagnetic force can also affect neighboring cells by ephaptic interaction. They also modulate levels of various growth factors that prevent autoimmune disease and inhibit tissue degeneration.

The H-reflex or "Hoffmann reflex" is obtained by electrode stimulation of the posterior tibial nerve in the popliteal space-at a slow rate with long duration-submaximal electrical shock, and recorded with surface electrodes over the gastrocnemius-soleus complex. The impulse travels up the sensory fibers to the spinal cord, synapses with the alpha motor neuron and returns down the motor fibers to the calf muscle. H-reflex latencies are long, in the 40 to 45 msec range. They are mostly carried out in the S1 root distribution and cannot be recorded consistently from other muscles.

Statement of the problem Is there any difference between high-power laser versus pulsed electromagnetic therapy on pain and hoffman reflex in lumbar radiculopathy?

Purposes of the study:

To compare between high-power laser versus pulsed electromagnetic therapy on pain and Hoffman reflex in lumbar radiculopathy.

02

Conditions studied

  • Lumbar Radiculopathy
  • Hoffman's Reflex
  • Pulsed Electromagnetic Therapy
  • Laser Therapy
  • Herniated Lumbar Disc
03

In context

Radiculopathy

483 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

This study's enrollment of 60 is close to the median of 60 across 373 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 48 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Sixty lumbar radiculopathy patients, of both sexes, will represent the sample.

      • The patient's age will range from 35 to 48 years old.
      • Patients with lumbar disc lesion at L5-S1 confirmed by MRI and latency in H- reflex.
      • Patients with unilateral sciatic radiating pain (from 5 to 8 by visual analogue scale).
      • Patient with normal cognitive function (MME more than 25)
      • from 20-29.9

Exclusion criteria

Exclusion Criteria:

  • The patients will be excluded if they have one of the followings:

    1. Patients with pacemakers and presence of electronic implants.
    2. Pregnant women.
    3. History of or existing malignant conditions, active tuberculosis of the lungs.
    4. Any medical condition that may cause sciatic nerve lesion except lumbar radiculopathy, (e.g., diabetes mellitus or collagen disorders).
    5. Cardiac, renal or hepatic failures recent or previous history of seizures or epilepsy.
    6. Previous surgery at L5-S1.
    7. Bleeding disorders.
    8. Serious infections of a viral, bacterial and fungal origin, conditions after organ transplants, upper motor neuron lesions.
    9. Patients with cognitive impairment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    study group 1 (G1a)

    study group (G1a) will receive 20 minutes of high-power laser therapy followed by 25 the same physical therapy program as control group.

    Device: high-power laser · Other: physiotherapy program

  • Experimental
    study group 2 (G1b)

    The study group 2 patients will receive 20 minutes of Pulsed electromagnetic field followed by 25 the same selected physiotherapy program as control group.

    Device: Pulsed electromagnetic field · Other: physiotherapy program

  • Experimental
    control group (G2)

    The control group patients will receive selected physiotherapy program.

    Other: physiotherapy program

Interventions

  • Devicehigh-power laser

    The study group (G1a) receive 20 minutes of high-power laser therapy followed by 25 the same physical therapy program as control group.

  • DevicePulsed electromagnetic field

    group 2 patients will receive 20 minutes of Pulsed electromagnetic field followed by 25 the same selected physiotherapy program as control group.

  • Otherphysiotherapy program

    Selected Physical therapy program in the form of: 1. Nerve gliding exercise for sciatic nerve. 2. Hot pack for 15 minutes, for 12 sessions. 3. Core stability exercise (static abdominal exercise, bridging, knee to chest).

06

What researchers measure

Primary outcomes

  1. The Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) is a tool for measuring pain intensity, using a continuous 10-centimeter line with "no pain" at one end (0) and "worst imaginable pain" at the other (10), where patients mark their current pain level, with a ruler used to measure the score from the zero mark for a score out of 10, commonly used in research and clinical settings to track pain changes.

    Time frame: baseline

  2. Hoffman reflex or H reflex

    H-reflex will be measured in the soleus muscle by stimulating the tibial nerve with a one-millisecond pulse at 0.2pps of H-max. The peak-to-peak amplitude of the highest recorded H-reflex and the latencies of four spaced traces for both lower extremities will be averaged for each participant. The soleus H-reflex will be evoked by tibial nerve stimulation in the popliteal fossa.

    Time frame: baseline

07

Study locations

1 site
  • Egyptair Hospital
    Cairo, Egypt
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in Aug 2026, 5 months.

Of 203 non-industry interventional studies with no phase under Radiculopathy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 30. This study's 5 months is below that.

Counting every sponsor, half of 215 studies reached it within 12 months; a quarter within 5 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 24, 2026
First posted
Feb 6, 2026
StartActual
Feb 15, 2026
Primary completionActual
Aug 12, 2026
CompletionActual
Aug 12, 2026
Last update
Aug 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07393750
Lead sponsor
Cairo University
Responsible party
Menna Tallah Sherif Hassan (Physiotherapist Egyptair Hospital, Cairo University) — Principal investigator
First posted
Feb 6, 2026
Start date
Feb 15, 2026
Primary completion
Aug 12, 2026
Completion
Aug 12, 2026
Last update
Aug 13, 2026

Study contacts

PROF. DR. MOSHERA HASSAN DARWISH, Professor of Physical Therapy
study chair · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion